Peapack-Gladstone Financial Corp’s VanEck Biotech ETF BBH Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Hold	7,203	–	–	0.02%	376
2025 Q4	$1.36M	Sell	7,203 -5	-0.1%	-$925	0.02%	374
2025 Q3	$1.19M	Sell	7,208 -230	-3%	-$37.5K	0.02%	391
2025 Q2	$1.14M	Sell	7,438 -717	-9%	-$107K	0.02%	386
2025 Q1	$1.28M	Sell	8,155 -1,355	-14%	-$220K	0.02%	375
2024 Q4	$1.49M	Sell	9,510 -1,100	-10%	-$185K	0.02%	353
2024 Q3	$1.88M	Sell	10,610 -1,553	-13%	-$276K	0.03%	339
2024 Q2	$2.05M	Sell	12,163 -3,072	-20%	-$502K	0.03%	321
2024 Q1	$2.53M	Sell	15,235 -3,715	-20%	-$615K	0.04%	293
2023 Q4	$3.13M	Sell	18,950 -3,554	-16%	-$547K	0.05%	256
2023 Q3	$3.5M	Sell	22,504 -2,072	-8%	-$331K	0.06%	235
2023 Q2	$3.83M	Sell	24,576 -3,827	-13%	-$611K	0.07%	230
2023 Q1	$4.78M	Buy	28,403 +23	+0.1%	+$3.72K	0.09%	217
2022 Q4	$4.53M	Sell	28,380 -473	-2%	-$74.9K	0.09%	211
2022 Q3	$4.06M	Buy	+28,853	New	+$4.36M	0.08%	218

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Peapack-Gladstone Financial Corp's BBH Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 7,203 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #376.

Peapack-Gladstone Financial Corp first reported a position in BBH in Q3 2022 and has held it in 15 quarters since. The position peaked at $4.78M in Q1 2023. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Peapack-Gladstone Financial Corp held 7,203 shares of VanEck Biotech ETF worth $1.35M as of Q1 2026.
Peapack-Gladstone Financial Corp left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up 0.02% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #376 holding.
Peapack-Gladstone Financial Corp first reported a position in VanEck Biotech ETF in Q3 2022 and has held it in 15 quarters since.
Peapack-Gladstone Financial Corp's VanEck Biotech ETF position peaked at $4.78M in Q1 2023.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.